Furthermore, the anti-AD activity of HA@Rhy@Hf-MOF, along with its inhibitory effects on Aβ aggregation and tau protein phosphorylation, was assessed through in vivo experiments. The gene discussed is MAPT; the disease is Alzheimer disease.